Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin on Colonic Sensorimotor Function
NCT01094808Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pregabalin in irritable bowel syndrome (IBS) and Visceral pain (3 arms), sponsored by Mayo Clinic. Primary endpoints: Sensory Threshold for Pain, Sensation Ratings for Pain and Gas at 30 mm Hg Distension and 3 more. Started Mar 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
irritable bowel syndrome (IBS)Visceral pain
Beyond the preview
Go deeper on NCT01094808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01094808.